Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Advanced Proteome Therapeutics Corporation V.APC.H

Alternate Symbol(s):  APTCF

Healthcare Biotechnology
Advanced Proteome Therapeutics Corporation is actively seeking additional funds to advance its core technologies for partnering and other potential revenue streams. It is not engaged in any activity.

TSXV:APC.H - Post Discussion

Advanced Proteome Therapeutics Corporation > Will go back to sleeping mode soon
View:
Post by Zorglub on Jul 30, 2022 9:23pm

Will go back to sleeping mode soon

Predicting that all that noise now will not last. Not the first time that is happening.
Comment by Goldnboy1 on Jul 31, 2022 2:18am
There is clearly someone bidding stock down here. The company has been active in the USA from what I'm told.  Rova-T comes to mind... Abbvie doing pretty good post Covid. Embarrassing loss attached to this drug. Reason for stage 3 clinical failure? Off-Target Toxicity.  APC's Conjugation Linker Tech specifically materially improves off-target toxicity.  By being ...more  
Comment by Zorglub on Jul 31, 2022 5:58am
I still didn't digest the 10 for 1 merge and lost confident on this one.
Comment by Goldnboy1 on Jul 31, 2022 8:26pm
The stock had a 10x run from the roll back date to the peaks of 2021.  Average down in this price window, you'll be happy you did.  Had you don't that on the roll back. You would have been able to get out with a solid gain. Can't freeze entirely when stocks are down. Gotta have that powder dry. 
Comment by Zorglub on Aug 02, 2022 11:03am
Yeah the share is climbing now. Its worth the wait (5 years) and hoping for dollars value soon.
Advanced Proteome Therapeutics Corporation
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities